These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 37032726)
1. Linked color imaging Wang ZX; Li LS; Su S; Li JP; Zhang B; Wang NJ; Liu SZ; Wang SS; Zhang S; Bi YW; Gao F; Shao Q; Xu N; Shao BZ; Yao Y; Liu F; Linghu EQ; Chai NL World J Gastroenterol; 2023 Mar; 29(12):1899-1910. PubMed ID: 37032726 [TBL] [Abstract][Full Text] [Related]
2. [Establishment and clinical validation of an artificial intelligence YOLOv51 model for the detection of precancerous lesions and superficial esophageal cancer in endoscopic procedure]. Wang SX; Ke Y; Liu YM; Liu SY; Song SB; He S; Zhang YM; Dou LZ; Liu Y; Liu XD; Wu HR; Su FX; Zhang FY; Zhang W; Wang GQ Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):395-401. PubMed ID: 35615795 [No Abstract] [Full Text] [Related]
3. Fujinon intelligent color enhancement for the diagnosis of early esophageal squamous cell carcinoma and precancerous lesion. Li YX; Shen L; Yu HG; Luo HS; Yu JP Turk J Gastroenterol; 2014 Aug; 25(4):365-9. PubMed ID: 25254516 [TBL] [Abstract][Full Text] [Related]
4. Assessment of novel endoscopic techniques for visualizing superficial esophageal squamous cell carcinoma: autofluorescence and narrow-band imaging. Yoshida Y; Goda K; Tajiri H; Urashima M; Yoshimura N; Kato T Dis Esophagus; 2009; 22(5):439-46. PubMed ID: 19191860 [TBL] [Abstract][Full Text] [Related]
5. Is blue light imaging without magnification satisfactory as screening for esophageal squamous cell carcinoma? Post-hoc analysis of multicenter randomized controlled trial. Ogata Y; Hatta W; Koike T; Takahashi S; Matsuhashi T; Iwai W; Asonuma S; Okata H; Ohyauchi M; Ito H; Abe Y; Sasaki Y; Kawamura M; Saito M; Uno K; Fujishima F; Nakamura T; Nakaya N; Iijima K; Masamune A Dig Endosc; 2024 Oct; 36(10):1118-1126. PubMed ID: 38494659 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of linked color imaging in the early detection of superficial esophageal squamous cell carcinomas. Nakamura K; Urabe Y; Oka S; Nagasaki N; Yorita N; Hata K; Masuda K; Kurihara M; Kotachi T; Boda T; Tanaka S; Chayama K Esophagus; 2021 Jan; 18(1):118-124. PubMed ID: 32447591 [TBL] [Abstract][Full Text] [Related]
7. A Five-Parameter Logistic Model to Predict the Possibility of Misdiagnosis for Improving the Specificity of Lugol Chromoendoscopy in the Diagnosis of Esophageal Neoplastic Lesions. Guo Z; Meng L; Tian S; Chen L; Shi H; Fan M; Lin R Front Oncol; 2021; 11():763375. PubMed ID: 35047392 [TBL] [Abstract][Full Text] [Related]
8. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia. Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564 [TBL] [Abstract][Full Text] [Related]
9. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus. Fagundes RB; de Barros SG; Pütten AC; Mello ES; Wagner M; Bassi LA; Bombassaro MA; Gobbi D; Souto EB Endoscopy; 1999 May; 31(4):281-5. PubMed ID: 10376452 [TBL] [Abstract][Full Text] [Related]
10. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial. Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469 [TBL] [Abstract][Full Text] [Related]
11. Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International Trial. Protano MA; Xu H; Wang G; Polydorides AD; Dawsey SM; Cui J; Xue L; Zhang F; Quang T; Pierce MC; Shin D; Schwarz RA; Bhutani MS; Lee M; Parikh N; Hur C; Xu W; Moshier E; Godbold J; Mitcham J; Hudson C; Richards-Kortum RR; Anandasabapathy S Gastroenterology; 2015 Aug; 149(2):321-329. PubMed ID: 25980753 [TBL] [Abstract][Full Text] [Related]
12. Impact of linked color imaging and blue laser imaging on the diagnosis of esophageal squamous cell carcinoma in iodine unstained areas. Tsunoda M; Miura Y; Osawa H; Nagayama M; Kagaya Y; Funayama Y; Kobayashi T; Togashi M; Hayashi H; Hiraoka Y; Nomoto Y; Iwashita C; Ino Y; Takahashi H; Fukuda H; Lefor AK; Yamamoto H Kaohsiung J Med Sci; 2023 May; 39(5):533-543. PubMed ID: 36810969 [TBL] [Abstract][Full Text] [Related]
13. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial. Gruner M; Denis A; Masliah C; Amil M; Metivier-Cesbron E; Luet D; Kaasis M; Coron E; Le Rhun M; Lecleire S; Antonietti M; Legoux JL; Lefrou L; Renkes P; Tarreirias AL; Balian P; Rey P; Prost B; Cellier C; Rahmi G; Samaha E; Fratte S; Guerrier B; Landel V; Touzet S; Ponchon T; Pioche M Endoscopy; 2021 Jul; 53(7):674-682. PubMed ID: 32698233 [TBL] [Abstract][Full Text] [Related]
14. Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial. Chaber-Ciopinska A; Kiprian D; Wieszczy P; Bielasik A; Bugajski M; Januszewicz W; Jarzabski A; Niemiec M; Mroz A; Kawecki A; Regula J; Kaminski MF Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 36916462 [TBL] [Abstract][Full Text] [Related]
15. Blue light imaging and linked color imaging as a screening mode for esophageal squamous cell carcinoma in high-risk patients: Multicenter randomized trial. Ogata Y; Hatta W; Koike T; Takahashi S; Matsuhashi T; Oikawa T; Iwai W; Asonuma S; Okata H; Ohyauchi M; Ito H; Abe Y; Sasaki Y; Kawamura M; Saito M; Uno K; Fujishima F; Nakamura T; Nakaya N; Iijima K; Masamune A Dig Endosc; 2023 Nov; 35(7):835-844. PubMed ID: 36802097 [TBL] [Abstract][Full Text] [Related]
16. A prospective randomized tandem gastroscopy pilot study of linked color imaging versus white light imaging for detection of upper gastrointestinal lesions. Wu CCH; Namasivayam V; Li JW; Khor CJ; Fock KM; Law NM; Wang LM; Ang TL J Gastroenterol Hepatol; 2021 Sep; 36(9):2562-2567. PubMed ID: 33811385 [TBL] [Abstract][Full Text] [Related]
17. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767 [TBL] [Abstract][Full Text] [Related]
18. Color information from linked color imaging is associated with invasion depth and vascular diameter in superficial esophageal squamous cell carcinoma. Kobayashi K; Miyahara R; Funasaka K; Furukawa K; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Nakaguro M; Okumura Y; Hirooka Y; Fujishiro M Dig Endosc; 2020 Jan; 32(1):65-73. PubMed ID: 31220372 [TBL] [Abstract][Full Text] [Related]
19. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma. Boller D; Spieler P; Schoenegg R; Neuweiler J; Kradolfer D; Studer R; Grossenbacher R; Zuercher U; Meyenberger C; Borovicka J Surg Endosc; 2009 Dec; 23(12):2748-54. PubMed ID: 19444514 [TBL] [Abstract][Full Text] [Related]
20. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis. Morita FH; Bernardo WM; Ide E; Rocha RS; Aquino JC; Minata MK; Yamazaki K; Marques SB; Sakai P; de Moura EG BMC Cancer; 2017 Jan; 17(1):54. PubMed ID: 28086818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]